22nd May 2008, Cumberland Hotel, London
Welcome to EPIC 2008 - a biotechnology conference which showcases over 60 UK and European biotechnology companies. It is the perfect opportunity to hear from and meet a range of growing biotechnology companies who need a combination of partners, investment and professional services to develop their companies. Two of the streams this year focus on companies with products in either pre-clinical or clinical trial stages. These will be of particular interest to pharmaceutical and biotechnology companies, venture capital companies and CROs. Having over 60 biotechnology companies presenting in one day makes EPIC a cost-effective day of evaluating companies for investment. The very popular University Challenge session again features along with one for Platform Technologies and Diagnostics.
Partnering and Licensing
|
Partnering is an essential component of the conference - especially for those seeking licensing deals. The on-line partnering enables delegates to arrange 1:1 meetings on the day with the presenting companies or fellow delegates. The upgraded online software for 2008 will be open until the day before the conference starts. |
Investment
|
Many of the presenting biotechnology companies are looking for funding through venture capital routes and have the opportunity to pitch to investors. Investment via development deals with big pharma is also an important another route for company development and EPIC provides the perfect platform to start negotiations. |
Networking
|
To compliment the structured partnering there will be informal networking throughout the day with a mix of companies, investors and scientists plus a networking drinks reception to end the day. Limited exhibition stands are available for company promotion and networking. |
University Challenge The challenge for university technology transfer is to spot exciting opportunities from groundbreaking, often early stage, science and to present a compelling commercial case to business and investors. Seven universities with strong records in licencing and starting spin-out companies will do just that. Each will present 2-3 new opportunities covering a large cross section of life science technologies. All the technologies will be available for exploitation through licence, collaboration, consultancy or other investment and the representatives of each institution will be available after the session for discussion.
If you are interested in presenting or sponsoring please contact the EPIC Director, Simon Tarpey at simontarpey@epicbiotech.com or on 00353 87 1386419.
For all other enquiries including exhibiting, please contact Charlotte Pollard at Ya-Ya Events on +44 207 989 2424 or charlotte@ya-ya.co.uk .
